Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies: comment
Author(s): ,
Hideo Wada
Affiliations:
Departments of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu, Japan
Correspondence: Hideo Wada, Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu, Mie 514‐8507, Japan|Tel.: +81 59 232 1111|E‐mail: wadahide@clin.medic.mie-u.ac.jp
,
Takeshi Matsumoto
Affiliations:
Blood Transfusion Service and Cell Therapy, Mie University Graduate School of Medicine, Tsu, Japan
,
Yoshiki Yamashita
Affiliations:
Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
,
Kohshi Ohishi
Affiliations:
Blood Transfusion Service and Cell Therapy, Mie University Graduate School of Medicine, Tsu, Japan
,
Makoto Ikejiri
Affiliations:
Central Laboratory, Mie University Graduate School of Medicine, Tsu, Japan
Naoyuki Katayama
Affiliations:
Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
ISTH Academy. Wada H. Mar 1, 2019; 273404
Hideo Wada
Hideo Wada
Login now to access Regular content available to all registered users.

Access to Premium content is currently a membership benefit.

Click here to join ISTH or renew your membership.

You may also access ISTH content "anytime, anywhere" with the FREE ISTH Academy App for iOS and Android.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies